WO2000044940A3 - Nucleic acid sequences for detecting genetic markers for cancer in a biological sample - Google Patents
Nucleic acid sequences for detecting genetic markers for cancer in a biological sample Download PDFInfo
- Publication number
- WO2000044940A3 WO2000044940A3 PCT/US2000/002270 US0002270W WO0044940A3 WO 2000044940 A3 WO2000044940 A3 WO 2000044940A3 US 0002270 W US0002270 W US 0002270W WO 0044940 A3 WO0044940 A3 WO 0044940A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prostate
- nucleic acid
- acid sequences
- genetic markers
- biological sample
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2360073A CA2360073C (en) | 1999-01-28 | 2000-01-28 | Probes and primers for detecting prostate specific antigen (psa) in a biological sample |
AU34755/00A AU767587B2 (en) | 1999-01-28 | 2000-01-28 | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
JP2000596180A JP4495349B2 (en) | 1999-01-28 | 2000-01-28 | Nucleic acid sequences for detecting cancer genetic markers in biological samples |
EP00913284A EP1151142A2 (en) | 1999-01-28 | 2000-01-28 | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11764099P | 1999-01-28 | 1999-01-28 | |
US60/117,640 | 1999-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000044940A2 WO2000044940A2 (en) | 2000-08-03 |
WO2000044940A3 true WO2000044940A3 (en) | 2000-12-07 |
Family
ID=22374015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/002270 WO2000044940A2 (en) | 1999-01-28 | 2000-01-28 | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
Country Status (6)
Country | Link |
---|---|
US (5) | US6551778B1 (en) |
EP (1) | EP1151142A2 (en) |
JP (1) | JP4495349B2 (en) |
AU (1) | AU767587B2 (en) |
CA (1) | CA2360073C (en) |
WO (1) | WO2000044940A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008765B1 (en) * | 1997-04-10 | 2006-03-07 | The Johns Hopkins University | PCA3, PCA3 genes, and methods of use |
WO2000044940A2 (en) * | 1999-01-28 | 2000-08-03 | Gen-Probe Incorporated | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
PT1222266E (en) * | 1999-09-29 | 2006-07-31 | Diagnocure Inc | PCA3 MESSENGER RNA IN BENEFICIAL AND MALIGNAL PROSTATE TISSUES |
WO2002042463A2 (en) * | 2000-11-21 | 2002-05-30 | Diadexus, Inc. | Compositions and methods relating to prostate specific genes and proteins |
WO2003068918A2 (en) * | 2002-02-11 | 2003-08-21 | Auburn University | High-sensitivity real-time polymerase chain reaction for detection of nucleic acids |
ES2427853T3 (en) | 2003-02-07 | 2013-11-04 | Diagnocure Inc. | Procedure to detect prostate cancer in a sample |
CN100577815C (en) * | 2003-05-01 | 2010-01-06 | 维里德克斯有限责任公司 | Intraoperative lymph node assay |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
US20070130694A1 (en) * | 2005-12-12 | 2007-06-14 | Michaels Emily W | Textile surface modification composition |
JP5340167B2 (en) | 2006-12-21 | 2013-11-13 | ジェン−プロウブ インコーポレイテッド | Methods and compositions for nucleic acid amplification |
US20110091883A1 (en) * | 2009-02-18 | 2011-04-21 | Helicos Biosciences Corporation | Methods for analyzing minute cellular nucleic acids |
CN102414554B (en) * | 2009-04-22 | 2014-11-26 | 威斯康星校友研究基金会 | Analyte detection using liquid crystals |
US9169512B2 (en) | 2009-07-01 | 2015-10-27 | Gen-Probe Incorporated | Methods and compositions for nucleic acid amplification |
SG10201912361VA (en) * | 2010-07-27 | 2020-02-27 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
US9938590B2 (en) | 2010-09-16 | 2018-04-10 | Gen-Probe Incorporated | Capture probes immobilizable via L-nucleotide tail |
US9255293B2 (en) | 2010-11-01 | 2016-02-09 | Gen-Probe Incorporated | Integrated capture and amplification of target nucleic acid for sequencing |
WO2013116774A1 (en) | 2012-02-01 | 2013-08-08 | Gen-Probe Incorporated | Asymmetric hairpin target capture oligomers |
SG11201608035UA (en) | 2014-03-28 | 2016-10-28 | Opko Diagnostics Llc | Compositions and methods related to diagnosis of prostate cancer |
DK3253800T3 (en) | 2015-03-27 | 2021-05-31 | Opko Diagnostics Llc | Prostate antigen standards and use thereof |
DE202017007129U1 (en) * | 2016-04-27 | 2019-08-29 | Gen-Probe Incorporated | Lysis reagent for blood cells |
CN111518170A (en) * | 2020-05-09 | 2020-08-11 | 新乡医学院 | FRET-based PSA fluorescent probe, preparation method and application thereof |
WO2023175434A1 (en) | 2022-03-15 | 2023-09-21 | Diagenode S.A. | Detection of methylation status of a dna sample |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021042A2 (en) * | 1995-01-04 | 1996-07-11 | Trustees Of Boston University | Primers for the pcr amplification of metastatic sequences |
WO1996021671A1 (en) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
WO1996026272A1 (en) * | 1995-02-24 | 1996-08-29 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
WO1997007242A1 (en) * | 1995-08-16 | 1997-02-27 | Steven Lehrer | Method for detecting circulating breast cancer cells |
WO1997039139A1 (en) * | 1996-04-16 | 1997-10-23 | Smithkline Beecham Corporation | A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer |
WO1998002449A1 (en) * | 1996-07-16 | 1998-01-22 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
EP0843006A2 (en) * | 1996-11-15 | 1998-05-20 | Eli Lilly And Company | Recombinant PSA expression vectors and assays using the same |
WO1998021365A2 (en) * | 1996-11-14 | 1998-05-22 | Mayo Foundation For Medical Education And Research | Method for detection of metastatic prostate cancer |
WO1998035031A1 (en) * | 1997-02-11 | 1998-08-13 | University Of Rochester Medical Center | Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
WO1998040513A1 (en) * | 1997-03-11 | 1998-09-17 | Ferrari Anna C | Method of detecting prostate cancer metastasis |
US5817798A (en) * | 1997-09-17 | 1998-10-06 | Abbott Laboratories | Rapid RNA isolation procedure in the presence of a transition metal ion |
WO1998046788A2 (en) * | 1997-04-11 | 1998-10-22 | Micromet Gesellschaft Für Biomedizinische Forschung Mbh | Primers and methods for the detection of disseminated tumor cells |
US5858673A (en) * | 1996-06-24 | 1999-01-12 | Charlotte-Mecklenburg Hospital Authority | Method for detecting prostate cells |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725010A (en) * | 1971-08-23 | 1973-04-03 | Beckman Instruments Inc | Apparatus for automatically performing chemical processes |
US5283174A (en) | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
AU662906B2 (en) | 1991-06-26 | 1995-09-21 | F. Hoffmann-La Roche Ag | Methods for detection of carcinoma metastases by nucleic acid amplification |
CA2135073C (en) | 1992-05-06 | 2002-11-19 | Daniel L. Kacian | Nucleic acid sequence amplification method, composition and kit |
US5786148A (en) | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
JPH08502889A (en) | 1992-10-29 | 1996-04-02 | トーマス・ジェファーソン・ユニバーシティ | Method of detecting micrometastases of prostate cancer |
US5674682A (en) * | 1992-10-29 | 1997-10-07 | Thomas Jefferson University | Nucleic acid primers for detecting micrometastasis of prostate cancer |
EP1757694A3 (en) | 1992-11-05 | 2008-02-27 | Sloan Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
US6103237A (en) * | 1993-07-22 | 2000-08-15 | Hybritech Incorporated | Stable variant hK2 polypeptide |
US5516639A (en) | 1993-07-22 | 1996-05-14 | Mayo Foundation For Medical Education And Research | Antibodies specific for human prostate glandular kallkrein |
US6569432B1 (en) * | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
FR2714062B1 (en) * | 1993-12-22 | 1996-02-16 | Bio Merieux | Modified promoter for RNA polymerase, its preparation and its applications. |
US5599677A (en) | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
AU2292495A (en) | 1994-04-15 | 1995-11-10 | Trustees Of Columbia University In The City Of New York, The | Method for molecular staging of prostate cancer |
WO1995030758A1 (en) * | 1994-05-10 | 1995-11-16 | Mayo Foundation For Medical Education And Research | Recombinant hk2 polypeptide |
US5698402A (en) | 1995-02-23 | 1997-12-16 | Dianon Systems, Inc. | Methods for diagnosing benign prostatic hyperplasia |
US5773292A (en) | 1995-06-05 | 1998-06-30 | Cornell University | Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood |
GB2302874B (en) * | 1995-06-29 | 1999-11-10 | Orion Yhtymae Oy | Novel proteins |
US5710007A (en) | 1995-09-29 | 1998-01-20 | Luderer; Albert A. | Methods for diagnosing prostatic adenocarcinoma |
US5861248A (en) | 1996-03-29 | 1999-01-19 | Urocor, Inc. | Biomarkers for detection of prostate cancer |
EP0891550A1 (en) | 1996-04-05 | 1999-01-20 | The Johns Hopkins University School Of Medicine | A method of enriching rare cells |
US6479263B1 (en) | 1996-11-14 | 2002-11-12 | Baylor College Of Medicine | Method for detection of micrometastatic prostate cancer |
US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7033827B2 (en) * | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
US6620922B1 (en) | 1997-02-25 | 2003-09-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
CA2286090C (en) | 1997-04-30 | 2013-01-08 | Hybritech Incorporated | Forms of prostate specific antigen and methods for their detection |
AU8259798A (en) * | 1997-06-20 | 1999-01-04 | George G Klee | Method for detection of breast cancer |
US8101349B2 (en) * | 1997-12-23 | 2012-01-24 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells and their methods of use II |
US20030215803A1 (en) * | 2000-12-07 | 2003-11-20 | Garcia Pablo Dominguez | Human genes and gene expression products isolated from human prostate |
JP2000069969A (en) | 1998-08-28 | 2000-03-07 | Hitachi Chem Co Ltd | PRIMER DNA AND DETECTION OF mRNA WHICH CODES FOR PROSTATE-SPECIFIC ANTIGEN USING THE SAME |
WO2000044940A2 (en) * | 1999-01-28 | 2000-08-03 | Gen-Probe Incorporated | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
AU2686200A (en) * | 1999-02-18 | 2000-09-04 | Compugen Ltd. | Novel nucleic acid and amino acid sequences |
EP1159431A2 (en) | 1999-03-11 | 2001-12-05 | Mount Sinai Hospital | Human kallikrein-like genes |
AU4484400A (en) | 1999-04-23 | 2000-11-10 | University Of Washington | Prostate-specific polynucleotides, polypeptides and their methods of use |
WO2000071711A2 (en) | 1999-05-20 | 2000-11-30 | Fahri Saatcioglu | Differentially expressed genes in prostate cancer |
AU2001241541A1 (en) * | 2000-02-17 | 2001-08-27 | Millennium Predictive Medicine, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
CN100422323C (en) | 2000-04-07 | 2008-10-01 | 荣研化学株式会社 | Method of amplifying nucleic acid by using double-stranded nucleic acid as template |
WO2001076622A2 (en) | 2000-04-10 | 2001-10-18 | Aventis Pasteur Limited | Immunogenic peptides derived from prostate-specific antigen (psa) and uses thereof |
CN100497655C (en) | 2000-05-01 | 2009-06-10 | 荣研化学株式会社 | Method for detecting product of nucleic acid synthesizing reaction |
CN1283807C (en) | 2001-06-18 | 2006-11-08 | 荣研化学株式会社 | Method of efficiently detecting double-stranded nucleic acid |
US20050112705A1 (en) * | 2002-03-14 | 2005-05-26 | Laurent Bracco | Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
US7348142B2 (en) * | 2002-03-29 | 2008-03-25 | Veridex, Lcc | Cancer diagnostic panel |
ES2427853T3 (en) | 2003-02-07 | 2013-11-04 | Diagnocure Inc. | Procedure to detect prostate cancer in a sample |
US20040223885A1 (en) * | 2003-05-06 | 2004-11-11 | Keen Randy E. | Apparatus for the automated synthesis of polynucleotides |
US20060008468A1 (en) * | 2004-06-17 | 2006-01-12 | Chih-Sheng Chiang | Combinations of tumor-associated antigens in diagnostics for various types of cancers |
-
2000
- 2000-01-28 WO PCT/US2000/002270 patent/WO2000044940A2/en active IP Right Grant
- 2000-01-28 JP JP2000596180A patent/JP4495349B2/en not_active Expired - Fee Related
- 2000-01-28 AU AU34755/00A patent/AU767587B2/en not_active Ceased
- 2000-01-28 EP EP00913284A patent/EP1151142A2/en not_active Withdrawn
- 2000-01-28 US US09/493,491 patent/US6551778B1/en not_active Expired - Lifetime
- 2000-01-28 CA CA2360073A patent/CA2360073C/en not_active Expired - Fee Related
-
2002
- 2002-10-17 US US10/273,707 patent/US6811985B2/en not_active Expired - Lifetime
-
2004
- 2004-10-28 US US10/978,145 patent/US7267956B2/en not_active Expired - Lifetime
-
2007
- 2007-08-13 US US11/838,168 patent/US20080026398A1/en not_active Abandoned
-
2008
- 2008-02-14 US US12/031,489 patent/US20090035773A1/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021042A2 (en) * | 1995-01-04 | 1996-07-11 | Trustees Of Boston University | Primers for the pcr amplification of metastatic sequences |
WO1996021671A1 (en) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
WO1996026272A1 (en) * | 1995-02-24 | 1996-08-29 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
WO1997007242A1 (en) * | 1995-08-16 | 1997-02-27 | Steven Lehrer | Method for detecting circulating breast cancer cells |
WO1997039139A1 (en) * | 1996-04-16 | 1997-10-23 | Smithkline Beecham Corporation | A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer |
US5858673A (en) * | 1996-06-24 | 1999-01-12 | Charlotte-Mecklenburg Hospital Authority | Method for detecting prostate cells |
WO1998002449A1 (en) * | 1996-07-16 | 1998-01-22 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
WO1998021365A2 (en) * | 1996-11-14 | 1998-05-22 | Mayo Foundation For Medical Education And Research | Method for detection of metastatic prostate cancer |
EP0843006A2 (en) * | 1996-11-15 | 1998-05-20 | Eli Lilly And Company | Recombinant PSA expression vectors and assays using the same |
WO1998035031A1 (en) * | 1997-02-11 | 1998-08-13 | University Of Rochester Medical Center | Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
WO1998040513A1 (en) * | 1997-03-11 | 1998-09-17 | Ferrari Anna C | Method of detecting prostate cancer metastasis |
WO1998046788A2 (en) * | 1997-04-11 | 1998-10-22 | Micromet Gesellschaft Für Biomedizinische Forschung Mbh | Primers and methods for the detection of disseminated tumor cells |
US5817798A (en) * | 1997-09-17 | 1998-10-06 | Abbott Laboratories | Rapid RNA isolation procedure in the presence of a transition metal ion |
Non-Patent Citations (4)
Title |
---|
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol. 36, no. 9, 1998, pages 671 - 681, ISSN: 1434-6621 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1998, DAHER ROSE ET AL: "Prostate-specific antigen and new related markers for prostate cancer.", XP002147837, Database accession no. PREV199900023053 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; October 1998 (1998-10-01), DIAMANDIS ELEFTHERIOS P: "Prostate-specific antigen: Its usefulness in clinical medicine.", XP002147838, Database accession no. PREV199800496950 * |
TRENDS IN ENDOCRINOLOGY AND METABOLISM, vol. 9, no. 8, October 1998 (1998-10-01), pages 310 - 316, ISSN: 1043-2760 * |
Also Published As
Publication number | Publication date |
---|---|
CA2360073A1 (en) | 2000-08-03 |
AU3475500A (en) | 2000-08-18 |
US20030104448A1 (en) | 2003-06-05 |
US20050118630A1 (en) | 2005-06-02 |
EP1151142A2 (en) | 2001-11-07 |
US6811985B2 (en) | 2004-11-02 |
US7267956B2 (en) | 2007-09-11 |
JP4495349B2 (en) | 2010-07-07 |
WO2000044940A2 (en) | 2000-08-03 |
US20090035773A1 (en) | 2009-02-05 |
AU767587B2 (en) | 2003-11-20 |
US20080026398A1 (en) | 2008-01-31 |
US6551778B1 (en) | 2003-04-22 |
CA2360073C (en) | 2011-01-18 |
JP2002535014A (en) | 2002-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000044940A3 (en) | Nucleic acid sequences for detecting genetic markers for cancer in a biological sample | |
WO2002057491A3 (en) | Direct multiplex characterization of genomic dna | |
IL153097A0 (en) | A process for selectively amplifying nucleic acid sequences | |
WO2006063065A3 (en) | Detection of nucleic acids from multiple types of human papillomaviruses | |
EP1184466A3 (en) | Target nucleic acid enrichment and amplification for array analysis | |
WO2006017083A3 (en) | Methods and compositions for phenotype identification based on nucleic acid methylation | |
WO2003060163A3 (en) | Discrimination and detection of target nucleotide sequences using mass spectrometry | |
WO2002103011A3 (en) | Selective gene amplification | |
WO2001004361A3 (en) | Detection of hiv-1 by nucleic acid amplification | |
WO2001071027A3 (en) | mRNA AMPLIFICATION | |
WO2002090572A3 (en) | Nucleic acid detection in pooled samples | |
ATE535618T1 (en) | SPECIFIC METHOD FOR DETECTING PROSTATE CANCER BASED ON THE PCA3 GENE AND KITS THEREOF | |
WO2002079411A3 (en) | Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification | |
WO2002024956A3 (en) | Genetic markers for tumors | |
WO2003020878A3 (en) | Amplification and detection reagents for hiv-1 | |
WO2003087390A3 (en) | Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples | |
EP1609874A3 (en) | System for searching for and identifying pathogenic agents | |
AU2740100A (en) | A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer | |
WO2003040397A3 (en) | Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons | |
WO2001051601A3 (en) | Methods for the storage and synthesis of nucleic acids | |
AU3830400A (en) | Methods of marking materials | |
WO2004062487A3 (en) | Methods of detecting gene expression in normal and cancerous cells | |
WO2003054149A3 (en) | Targeted genetic risk-stratification using microarrays | |
EP0919633A3 (en) | Detection of Neisseria Gonorrhoeae by amplification and detection of its nucleic acid | |
WO2004033485A3 (en) | Nucleic acid supported protein complementation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 34755/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2360073 Country of ref document: CA Ref country code: CA Ref document number: 2360073 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000913284 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 596180 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000913284 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 34755/00 Country of ref document: AU |